Characterisation of integrin-linked kinase signalling in sporadic human colon cancer
2003
Integrin-Linked Kinase Signaling in Colon Cancer
Sample size: 38
publication
Evidence: moderate
Author Information
Author(s): Marotta A, Parhar K, Owen D, Dedhar S, Salh B
Primary Institution: Jack Bell Research Center
Hypothesis
Is the ILK signaling pathway disrupted in sporadic cases of colon cancer?
Conclusion
Dysregulation of ILK signaling is an important early event in the genesis of human colon cancer.
Supporting Evidence
- ILK is hyperexpressed in malignant crypts from both primary and metastatic lesions.
- There was approximately a 2–9-fold increase in ILK activity in cancerous tissues compared to normal.
- Changes in ILK activity coincide with changes in downstream targets like GSK3β.
Takeaway
This study found that a protein called ILK is more active in colon cancer, which might help the cancer grow.
Methodology
The study involved immunohistochemical analysis and biochemical activity assessment of ILK in colon cancer samples.
Limitations
The study did not assess the effects of ILK activity at the invasive front of tumors.
Participant Demographics
The study included 38 cases of human colon cancer, with 16 cases having lymph node metastases.
Statistical Information
P-Value
p<0.0005
Statistical Significance
p<0.0005
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website